Cite
HARVARD Citation
McCurdy, S. et al. (2020). Efficacy of delafloxacin versus moxifloxacin against atypical bacterial respiratory pathogens in adults with community-acquired bacterial pneumonia (CABP): Data from the Delafloxacin Phase 3 CABP Trial. International journal of infectious diseases. pp. 374-379. [Online].